14 SI
LIVE

Serial Number

79295832

Owner

Veritas In Silico Inc.

Attorney

Sean K. Owens

Filing Date

Jun 5, 2020

Add to watchlist:

No watchlists yet
View on USPTO

14 SI Trademark

Serial Number: 79295832 • Registration: 6708925

14 SI is a trademark filed by Veritas In Silico Inc. on June 5, 2020. The trademark is classified under Class 41 (Education & Entertainment), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Veritas In Silico Inc. (3 trademarks)

1-11-1, Nishi-Gotanda,

Entity Type: 03

Trademark Details

Filing Date

June 5, 2020

Registration Date

April 26, 2022

Published for Opposition

February 8, 2022

Goods & Services

Educational and instruction services, namely, organizing events for educational and teaching purposes relating to arts, crafts, sports and general knowledge; teaching in the field of drug discovery and development; educating at universities and graduate schools; arranging, conducting and organization of seminars; arranging, conducting and organization of symposiums, lecture meetings, workshops and study groups; arranging, conducting and organization of educational seminars, symposiums, lecture meetings, workshops and study groups in the field of drug discovery and development; providing online non-downloadable electronic publications in the nature of magazines, newsletters, journals and books in the field of nucleic acids, pharmaceuticals, drug discovery and development, medicine, chemicals and engineering; reference libraries of literature and documentary records; book rental; providing online music, sound recordings, videos featuring information and instruction on nucleic acids, pharmaceuticals, drug discovery and development, medicine, chemicals and engineering, images and character text information, non-downloadable; educational services in the nature of providing exhibits of academic materials in the field of nucleic acids, pharmaceuticals, drug discovery and development, medicine, chemicals and engineering; art exhibitions; publication of books; movie theatre presentations, namely, movie showing and movie film production and distribution; production of videotape film in the field of education, culture, entertainment or sports, not for movies or television programs and not for advertising or publicity

Designing of machines, apparatus, instruments, including their parts, or systems composed of such machines, apparatus and instruments; pharmaceutical, medicine and chemical industrial design services for use in medicines and engineering design services, not for advertising; computer software design, computer programming, and maintenance of computer software; designing, programming and maintenance of computer software having artificial intelligence functionality; computer software design, computer programming, and maintenance of computer software for use in scientific and technical analysis of data from artificial intelligence; computer software design, computer programming, and maintenance of computer software for use in analysis, testing, screening, designing, development or research on nucleic acids, pharmaceuticals or chemicals; computer software design, computer programming, and maintenance of computer software for use in drug discovery screening; computer software design, computer programming, and maintenance of computer software for use in genome research or the development of consumer health products, treatments, pharmaceutical preparations, diagnostic instruments or foodstuffs; data conversion of electronic information using computers technological advice relating to computers, automobiles and other industrial machines requiring highly specialized knowledge, skills and experiences for proper operation, namely, computer technology consultancy, automobile transmission diagnostic consulting and industrial machine part design consulting; scientific research, testing and analysis in the field of nucleic acids, pharmaceuticals, drug discovery and development, medicines, chemicals and engineering; quality control assessment services for others; testing, inspection or research of pharmaceuticals, cosmetics or foodstuffs; testing, inspection or research of chemicals or reagents; providing information and consultancy on testing, inspection or research of pharmaceuticals, chemicals, reagents, cosmetics or foodstuffs; scientific or laboratory testing, inspection or research of nucleic acids, chemicals and pharmaceuticals for drug development and medical research purposes, and providing scientific information and research consultancy relating thereto; testing or scientific research on biotechnology and providing scientific information and research consultancy relating thereto; genomic experiments, analyses, research, assays, tests, inspection, detection or verification, namely, scientific genomic analyses, scientific genomic research, custom design and development of biochemical genomic assays, genome amplification and functional and structural analysis of genomes; scientific research consultancy, advice and providing information in the field of genomic experiments, analyses, research, assays, tests, inspection, detection or verification; scientific and technological services, namely, testing, analysis surveying, research or data analysis in the field of biomedicine, genome biology, pharmacogenomics, diagnostics, clinical trials and bioengineering; research and development of vaccines and medicines; development of pharmaceutical preparations and medicines; conducting clinical trials for pharmaceuticals for others; research on building construction or city planning; testing or research on prevention of pollution; testing or research on electricity; testing or research on civil engineering; testing, inspection or research on agriculture, livestock breeding or fisheries; testing or research on machines, apparatus and instruments, namely, testing the functionality of machines, research on machines and technology research in the field of medical instruments and drug manufacturing machines; rental of measuring apparatus; rental of computers; providing computer programs on data networks, namely, providing temporary use of non-downloadable computer software for enabling, supporting and accelerating processes of RNA-targeted drug discovery and development for use in research and development of nucleic acids, pharmaceuticals, medicines and chemicals; cloud computing, namely, providing temporary use of on-line non-downloadable cloud computing software for enabling, supporting and accelerating processes of RNA-targeted drug discovery and development for use in research and development of nucleic acids, pharmaceuticals, medicines and chemicals; software as a service (SaaS) services featuring software for enabling, supporting and accelerating processes of RNA-targeted drug discovery and development for use in research and development of nucleic acids, pharmaceuticals, medicines and chemicals; electronic storage services for archiving electronic data; cloud server storage services on the internet for electronic files; providing temporary use of non-downloadable computer software having artificial intelligence functionality on data networks for use in research and development of nucleic acids, pharmaceuticals, medicines and chemicals; providing online non-downloadable computer software for analysis of science and technology data based on artificial intelligence (AI) technology; providing online non-downloadable computer software for analyzing, testing, screening, designing, development and research of nucleic acids, pharmaceuticals and chemicals; providing online non-downloadable computer software for drug discovery screening; providing online non-downloadable computer software for genome research and development research of consumer health products, treatments, pharmaceutical preparations, diagnostic instruments and foodstuffs; rental of laboratory apparatus and instruments

Filing History

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Aug 20, 2024 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 20, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 20, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 20, 2024 REAP
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 11, 2022 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Oct 11, 2022 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 11, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 11, 2022 REAP
FINAL DECISION TRANSACTION PROCESSED BY IB
Sep 20, 2022 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Aug 31, 2022 FICS
FINAL DISPOSITION PROCESSED
Aug 31, 2022 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jul 26, 2022 FICR
REGISTERED-PRINCIPAL REGISTER
Apr 26, 2022 R.PR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Apr 4, 2022 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 16, 2022 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Mar 16, 2022 OPNR
ASSIGNED TO EXAMINER
Mar 7, 2022 DOCK
NOTIFICATION PROCESSED BY IB
Feb 14, 2022 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 8, 2022 NPUB
PUBLISHED FOR OPPOSITION
Feb 8, 2022 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 19, 2022 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jan 19, 2022 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 19, 2022 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jan 5, 2022 PREV
ASSIGNED TO LIE
Jan 4, 2022 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 3, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 30, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 30, 2021 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Nov 30, 2021 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Jun 11, 2021 GNFN
FINAL REFUSAL E-MAILED
Jun 11, 2021 GNFR
FINAL REFUSAL WRITTEN
Jun 11, 2021 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
May 10, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 10, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 10, 2021 TROA
REFUSAL PROCESSED BY IB
Dec 7, 2020 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Nov 17, 2020 RFCS
REFUSAL PROCESSED BY MPU
Nov 17, 2020 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Oct 27, 2020 RFCR
NON-FINAL ACTION WRITTEN
Oct 26, 2020 CNRT
APPLICATION FILING RECEIPT MAILED
Oct 23, 2020 MAFR
ASSIGNED TO EXAMINER
Oct 19, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 19, 2020 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Oct 15, 2020 REPR